Literature DB >> 33446481

Covid-19: Past infection provides 83% protection for five months but may not stop transmission, study finds.

Elisabeth Mahase1.   

Abstract

Entities:  

Year:  2021        PMID: 33446481     DOI: 10.1136/bmj.n124

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  8 in total

1.  Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern.

Authors:  Donal T Skelly; Adam C Harding; Eleanor Barnes; Miles W Carroll; William S James; Javier Gilbert-Jaramillo; Michael L Knight; Stephanie Longet; Anthony Brown; Sandra Adele; Emily Adland; Helen Brown; Tom Tipton; Lizzie Stafford; Alexander J Mentzer; Síle A Johnson; Ali Amini; Tiong Kit Tan; Lisa Schimanski; Kuan-Ying A Huang; Pramila Rijal; John Frater; Philip Goulder; Christopher P Conlon; Katie Jeffery; Christina Dold; Andrew J Pollard; Alex Sigal; Tulio de Oliveira; Alain R Townsend; Paul Klenerman; Susanna J Dunachie
Journal:  Nat Commun       Date:  2021-08-17       Impact factor: 14.919

2.  Shell Disorder Models Detect That Omicron Has Harder Shells with Attenuation but Is Not a Descendant of the Wuhan-Hu-1 SARS-CoV-2.

Authors:  Gerard Kian-Meng Goh; A Keith Dunker; James A Foster; Vladimir N Uversky
Journal:  Biomolecules       Date:  2022-04-25

Review 3.  COVID-19 vaccines: Frequently asked questions and updated answers.

Authors:  M Lefebvre; N Vignier; B Pitard; E Botelho-Nevers; B Wyplosz; R Cohen; O Epaulard
Journal:  Infect Dis Now       Date:  2021-02-27

4.  The mathematics of multiple lockdowns.

Authors:  Antonio Scala
Journal:  Sci Rep       Date:  2021-04-13       Impact factor: 4.379

5.  How to continue COVID-19 vaccine clinical trials? The ethics of vaccine research in a time of pandemic.

Authors:  Silvia Ceruti; Marco Cosentino; Mario Picozzi
Journal:  Clin Ethics       Date:  2022-03

6.  Durability of Antibody Responses to SARS-CoV-2 Infection and Its Relationship to Disease Severity Assessed Using a Commercially Available Assay.

Authors:  Alanoud Alshami; Rabab Al Attas; Hadeel Anan; Aroub Al Maghrabi; Salim Ghandorah; Amani Mohammed; Abdulbary Alhalimi; Jumana Al-Jishi; Hadi Alqahtani
Journal:  Front Microbiol       Date:  2021-12-03       Impact factor: 5.640

7.  A case of COVID-19 reinfection in a hemodialysis patient: the role of antibody in SARS-CoV-2 infection.

Authors:  Hiroko Beppu; Toshie Ogawa; Masahiro Ishikane; Tomoko Kawanishi; Tatsuya Fukuda; Lubuna Sato; Akihiro Matsunaga; Kenji Maeda; Daisuke Katagiri; Yukihito Ishizaka; Hiroaki Mitsuya; Norio Ohmagari; Fumihiko Yasui; Michinori Kohara; Kan Kikuchi; Sachiko Wakai
Journal:  CEN Case Rep       Date:  2022-03-09

8.  COVID-19 reinfection in Liberia: Implication for improving disease surveillance.

Authors:  Godwin E Akpan; Luke Bawo; Maame Amo-Addae; Jallah Kennedy; C Sanford Wesseh; Faith Whesseh; Peter Adewuyi; Lily Sanvee-Blebo; Joseph Babalola; Himiede W W Sesay; Trokon O Yeabah; Dikena Jackson; Fulton Shannon; Chukwuma David Umeokonkwo; Abraham W Nyenswah; Jane Macauley; Wilhelmina Jallah
Journal:  PLoS One       Date:  2022-03-24       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.